Connect with us

Health

The common pill that’s killing in the shadow of the opioid crisis

Editor

Published

on

Wendy Golden with photos of her son Kody Cook at her home in Amherst, N.S. (Steve Lawrence/CBC)

To this day, Wendy Golden has no idea why her son Kody Cook chose to swallow what he did on June 24, 2014. Sure, he smoked weed and liked his Budweiser, but the autopsy would later classify him as a “naive” user. In other words, he was hardly an addict.

That night, around 11 p.m., Golden arrived back at her Amherst, N.S., home after her shift at a local convenience store to find Kody lying on her couch. When she went to rouse the 20-year-old to go to bed, she realized he wasn’t breathing.

“When the ambulance arrived, I said, ‘Please, whatever you do, don’t let him go. I can’t lose another son,'” says Golden, who had another son die in a 2009 house fire. “That’s the way it was meant to be, I guess.”

A mix of prescription drugs

In the following hours the story of what happened became clear. A co-worker at the fish plant where Kody worked in Grand-Barachois, N.B., had given him a dose of his prescription methadone and a second drug, a sedative called clonazepam, part of a group of medications known as benzodiazepines.

Witnesses heard him tell Kody that he now owed him $7, in the same way someone might exchange a favour for a cup of coffee.

Golden said she looked for the co-worker who shared prescription drugs with Kody to share responsibility. (Steve Lawrence/CBC)

From illicit fentanyl being smuggled into the country to painkiller pills being sold between friends to the misuse of addiction-treatment medications like methadone, more than 9,000 Canadians have died over the last three years from an opioid-related overdose. Thousands more were hospitalized.

But lost in much of the public discussion is the largely overlooked role being played by a different kind of drug, benzodiazepines, particularly in areas of the country like Nova Scotia where the overdose problem continues to be primarily driven by prescription medications diverted into the illegal drug market.

Prescribing medications that kill

The harsh truth, according to addiction experts, is an ill-equipped health-care system is partly to blame. Too many family and acute-care doctors don’t have the training to treat addictions. Some are even prescribing medications that could ultimately kill their patients.

Benzodiazepines have been used since the 1960s to treat seizures, insomnia and anxiety. They include common medications like diazepam, lorazepam and clonazepam, the same drug that helped kill Kody Cook. The big brand names are ubiquitous: Valium, Ativan and Xanax.

Such medications work on different receptors in the central nervous system than opioids. However, both potentially depress the respiratory system and, when taken together, work “synergistically” with sometimes lethal consequences. Breathing can slow to a stop.

“There’s really good evidence that if you give benzodiazepines together with opioids you increase the risk of death by intoxication,” says Dr. Matthew Bowes, Nova Scotia’s chief medical examiner. “That certainly bears out in our experience here in the morgue.”

Dr. Matthew Bowes, chief medical examiner of Nova Scotia, says he has seen that mixing benzodiazepines with opioids can increase the risk of death by intoxication. (Robert Short/CBC)

It bears out in statistics, too. In Nova Scotia, benzodiazepines contributed to death in well over half of the 442 opioid-related fatalities from 2011 to the end of October, most of them accidental overdoses.

The ratio is similar in New Brunswick. In Manitoba, it is above 40 per cent. In Ontario, one study that looked at data up to 2015 found benzodiazepines in half of opioid-related deaths.

Warning in U.S. over benzodiazepines

There are no pan-Canadian numbers, and it appears the role of benzodiazepines is less prevalent in some areas hard hit by the fentanyl epidemic. In Alberta, for instance, they contribute to death in relatively few cases.

Still, 30 per cent of opioid-related deaths in the United States involve a benzodiazepine, according to the National Institute on Drug Abuse. Federal officials in the U.S. have even issued a “black box warning” — the most severe of all warnings —  about the risks of combining certain opioids with benzodiazepines.

“The problem’s not new,” says Dave Martell, a doctor from Lunenburg, N.S., who specializes in addiction treatment and runs several rural clinics in the southern part of the province.

“I think we’re just uncovering benzodiazepines as an issue because we’re just starting to look at it. They’ve actually been problematic in terms of prescribing practices since the 1970s. It’s been a hidden thing.”

Opioid users may have mental-health issues they are medicating with benzodiazepines. In other cases, patients on benzodiazepines for anxiety or insomnia may be injured in a car accident or at work, and be prescribed opioids for pain.

People addicted to opioids often face a roller-coaster of having a supply and then running out. Running out means withdrawal, which leads to panic attacks, restlessness and the feeling of being hit by the worst flu imaginable.

Desperate for relief, they reach for anything. Some buy anti-anxiety drugs off the street. Others turn to family physicians or emergency room doctors, walking out with prescriptions for benzodiazepines. When they return to opioids, the combination can be lethal.

“In this current overdose epidemic, what it’s done really is pull back the curtain to really show that we don’t have a functioning addictions system,” according to Dr. Keith Ahamad, a family doctor and researcher at the British Columbia Centre on Substance Use. “In fact, the health-care system is really worsening the situation.”

Clonazepam combined with methadone is what led to the death of Kody Cook on June 24, 2014, in Amherst, N.S. (Alex Lynch/CBC)

As part of his work, Ahamad and a group of researchers followed a cohort of nearly 3,000 intravenous drug users in downtown Vancouver from 1996 until 2013. They found those who also used benzodiazepines were more likely to die.

Another study that looked at 2,833 opioid-related deaths in Ontario from 2013 to 2016 found that in about 30 per cent of cases, the victim had an active benzodiazepine prescription. In hundreds of cases they were also being prescribed an opioid at the same time.

Fentanyl crisis has diverted attention

Tara Gomes, a co-author of the report, says there’s a growing awareness of the risk of taking the two drugs together. However, while abuse of prescribed opioids has been known as a problem for years, the conversation has swiftly moved on to the fentanyl crisis gripping parts of Canada.

“We can’t ignore this huge surge of deaths in fentanyl, and that is obviously an alarming fact that we have to address right now,” says Gomes, a drug policy researcher with St. Michael’s Hospital in Toronto. “But what we’re also noticing is there isn’t a huge change in the rate of opioid-related deaths from prescribed opioids.” 

Ernie LeBlanc, father of Jason LeBlanc, 42, says his son long battled addiction before his overdose death in a Cape Breton Correctional Facility cell. (Andrew Vaughan/Canadian Press)

Jason Marcel LeBlanc had a bag in his pocket full of the benzodiazepine bromezapam when he died in the early hours of Jan. 31, 2016, in a holding cell at the Cape Breton Correctional Facility in Sydney, N.S.

Guards at the jail had failed to find the pills when he arrived 14 hours earlier after being picked up by police for a parole violation. He’d taken illicitly bought methadone before his arrest, and video from his cell appeared to show him downing some of the bromezapam. The combination killed him.

His father, Ernie LeBlanc, says his 42-year-old son suffered bouts of severe anxiety related to his long struggle with an opioid addiction that had started when he worked in the West. He was self-medicating with “nerve pills” bought off the street.

Anxiety among addicts

“Your anxiety gets that bad, you’ve got to have something to help you,” says LeBlanc. “Just like if you’re an alcoholic. If you’re an alcoholic and you’re dying for a drink and your nerves get bad, and this gets bad — anxiety — first thing they’re going to have to do is have a drink, isn’t it?”

The cocktail of benzodiazepines and opioids can be so deadly that the combination has even been used to put prisoners to death in the U.S.

In 2014, Ohio executed convicted killer Dennis McGuire using the benzodiazepine midazolam, a surgical sedative, and the opioid hydromorphone. It took him 25 minutes to die and he appeared to gasp for breath. The same combination was also used later that year in Arizona. In that case, it took two hours.

Xanax is a benzodiazepine. After police intercept a supply of opioids, people often come to the emergency room and get a prescription for benzodiazepine to help with their withdrawal. (Alex Lynch/CBC)

It’s believed about 500,000 benzodiazepine prescriptions are dispensed each year in Nova Scotia. This fall, Nova Scotia added the drug group to its prescription monitoring program, which tracks the dispensing of certain medications and can flag worrisome amounts or treatments.

Dr. Robert Strang, Nova Scotia’s chief medical officer of health, says it’s been long known that benzodiazepines are being over-prescribed and overused. The drugs have a limited set of uses, he says, and are mostly meant to be taken only short term.

Martell, the addictions doctor on Nova Scotia’s South Shore, is more blunt: “With this prescription monitor doing this new monitoring, I think they’re going to uncover things that are kind of horrifying and just ignored because the opioid crisis is kind of taking the headlines away from every other problem in the health-care system.”

Doctors may not know potential impact

He says in his area a police drug bust that temporarily chokes out the street supply of opioids will often be followed by a “flood” of people to local emergency rooms and doctors’ offices, seeking something that will temper the misery of withdrawal. Too often, he says, they get it.

“Saying, ‘If you just take this Valium or Ativan, this will help you while you’re going through your withdrawal.’ Not realizing that what they’re giving them is a supply of something that could potentially kill them combined with the drug that they’re having trouble trying to get away from.”

Originally from Arichat, N.S., Martell says he “fumbled into” addictions medicine while beginning to set up a family practice in Lunenburg about 14 years ago. He didn’t have a large patient roster, so he offered to work at the local hospital detox unit, which had been without a doctor for years.

He struggled at first, with little training or background in how to help his patients. What he discovered, he says, is that learning to treat addiction isn’t hard, and he’s optimistic Nova Scotia is making strides in that area of doctor education.

But early on, he did have a number of patients die of overdoses, and became “acutely aware” of what can happen when benzodiazepines are combined with opioids. “When somebody dies, especially somebody young, you tend to remember that.”

Kody Cook, left, had been planning a move to Moncton, N.B., before his death. (Submitted by Wendy Golden)

Wendy Golden now lives in a small white bungalow on the outskirts of Amherst with a cat and two rescue dogs. There are no photos of her son Kody on the walls. She used to have a shrine to him, but put it in storage. It had, in her words, become “unhealthy.”

But her memories of him are vivid — his loyalty, honesty and unique sense of humour. How he was making his way in his young life, preparing to move away from home to nearby Moncton, N.B.

Her message now is simple: don’t share or sell prescriptions.

“You don’t know what that person took earlier. They already may be on a medication that can mix with the medication you have. And the combination can be lethal.”

After Kody died, she urged police to investigate. There were initially jurisdictional issues, because the drugs had been consumed in New Brunswick but the death was in Nova Scotia. Then there was the question of whether charges could be laid.

Man charged in Kody’s death

But she persisted. Kody alone made the choice he did that day, she says, and lost his life over $7 of prescription drugs. But she didn’t want her son to be looked on as “another druggie.” And she felt the co-worker who sold to him should be held responsible for the part he played.

“That’s why I chose to fight to have something done,” she says.

In December 2015, that co-worker, a man named Neil Calder, was charged with manslaughter and drug trafficking. Six months later he pleaded guilty and was handed two years and two months in prison. His sentence officially ended in September.

Golden remembers him apologizing in court, saying he had never meant for Kody to die. She didn’t realize it at the time, but the apology would make things easier.

“That’s all I wanted him to do in the beginning, was stand up and say, ‘Yes, it was mine.’ Take responsibility for his actions,” Golden says. “That was enough for me.”

Source link

قالب وردپرس

Health

Post-vaccine surge? Michigan’s spring coronavirus case spike close to previous year’s autumn high

Editor

Published

on

By

(Natural News) The spike in new Wuhan coronavirus infections recorded in Michigan over the spring is similar to a spike seen during the 2020 fall season. According to a Wall Street Journal analysis, the state’s daily coronavirus case count averaged more than 7,000 for almost two weeks – before taking a slight dip to 6,891 on April 20. This echoed similar figures back in November and December 2020, which saw sharp rises in infections for those two months before plunging.

Back in autumn of last year, Michigan averaged more than 7,000 cases per day for a span of 10 days. New infections dropped slightly, then briefly spiked as the December holidays approached. It then fell to the low 1,000s for the succeeding two months – until ascending again in March.

According to University of Michigan internal medicine professor Dr. Vikas Parekh, the sudden increase in new infections could be attributed to several factors. Among the factors he cited was re-openings, which increased people’s interactions and mobility. Parekh said the loosened restrictions contributed to the spread of the highly contagious U.K. B117 variant.

“As the B117 variant spreads nationally, we will likely see other stats [with] their own surges – although I hope none are as bad as Michigan,” the professor remarked. He continued: “The milestone just tells us we are not yet in the clear, especially as we still have large portions of our population who are not vaccinated yet.”

Parekh also expressed optimism over the lower daily caseloads the Great Lakes State reported. He said he believes both cases and hospitalizations have plateaued and will likely decline soon. The professor commented: “[COVID-19] positivity has been declining now for one week, which is usually a leading indicator of case decline.”

Meanwhile, the state cited younger populations and youth sports, such as basketball, wrestling and hockey, to increase new COVID-19 infections. Because of this, Gov. Gretchen Whitmer called to suspend youth sports and indoor dining in the state. She also exhorted high schools to conduct remote class sessions for two weeks to curb the spread of the pathogen.

Michigan still experienced the spike in cases despite having one of the highest vaccination rates in the country

During the opening stages of the U.S.’s immunization drive against COVID-19, Michigan boasted of having one of the highest vaccination rates nationwide. A report by Bridge Michigan even noted the initial “frenzy for vaccines” that “far exceeded the state’s limited supply.” But things have appeared to turn around for Michigan, as it now struggles to reach the 70 percent vaccination rate needed for herd immunity.

Continue Reading

Health

Scottish mom’s legs turn into a pair of “giant blisters” after first dose of AstraZeneca’s coronavirus vaccine

Editor

Published

on

By

(Natural News) Sarah Beuckmann of Glasgow, Scotland, felt a tingling sensation in her legs and noticed a rash flaring up around her ankles a week after getting her first dose of AstraZeneca’s coronavirus (COVID-19) vaccine on March 18.

She also had flu-like symptoms right after the vaccination.

Beuckmann called her doctor to arrange an appointment the morning she noticed the rash, but by the afternoon her skin was already breaking out into blood-filled blisters. Blisters also appeared on her legs, hands, face, arms and bottom.

“I ended up asking my husband to take me to A&E,” said Beuckmann, referring to “accident and emergency,” the equivalent of an emergency room (ER). “When I got there, my heart rate was sitting at 160bpm, which they were very concerned about. I got put on an ECG machine.”

Doctors determine AstraZeneca’s COVID-19 vaccine triggers the rash

Medics carried out tests for HIV, herpes and other skin conditions to work out what triggered the rash, but all results came back negative. Doctors finally determined that the vaccine caused her rare reaction after carrying out two biopsies.

“Once they found that it was a reaction to the vaccine, they put me on steroids and that really seems to be helping my progress,” said Beuckmann. She had been advised by her doctor not to get the second dose of AstraZeneca’s COVID-19 vaccine because of her reaction.

Beuckmann spent 16 days at Queen Elizabeth University Hospital. She was discharged to recover at home. The 34-year-old mother of one is currently wheelchair-bound due to the bandages on her legs and blisters on the soles of her feet. She may need physiotherapy to help strengthen her leg muscles.

“They are starting to heal and they’re looking a lot better than they were but as the blisters started to get worse, they all sort of merged together,” she said. “I didn’t know what was going on.”

With the blisters merging, her legs have looked like a pair of “giant blisters.” Beuckmann admitted that at one point she feared her legs might have to be amputated.

Dermatologist agrees COVID-19 vaccine causes the blisters

Dr. Emma Wedgeworth, a consultant dermatologist and spokeswoman at the British Skin Foundation, agreed that Beuckmann had likely suffered a reaction to the vaccine.

“Vaccines are designed to activate the immune system. Occasionally people will have quite dramatic activation of their immune systems which, as happened in this case, can manifest in their skin” Wedgeworth told MailOnline. “This poor lady had a very severe reaction, which thankfully is extremely rare.”

It is not clear why Beuckmann, who works in retail, was invited for a vaccine. Scotland’s vaccine rollout was focused on people over the age of 50 when she got vaccinated, although vaccines are available to those who are considered at risk from the virus, or live with someone considered vulnerable.

At least 20 million Briton have had AstraZeneca’s COVID-19 vaccine, which drug regulators say causes a rash in one percent of cases. They say rashes caused by the jab tend to go away within a week.

Continue Reading

Health

Trojan labs? Chinese biotech company offers to build COVID testing labs in six states

Editor

Published

on

By

In 2012, BGI acquired Complete Genomics, a DNA sequencing company and equipment maker. The funds for the $117.6 million purchase were raised from Chinese venture capitals. The company has expanded its footprint globally. According to its website, BGI conducts business in more than 100 countries and areas and has 11 offices and labs in the U.S.

People are concerned about China’s access to American DNA data

Some said that with Complete Genomics providing an American base, BGI would have access to more DNA samples from Americans, helping it compile a huge database of genetic information. Some also worried about the protection of the genetic information’s privacy.

According to a 2019 report from the U.S.–China Economic and Security Review Commission (USCC), BGI “has formed numerous partnerships with U.S. healthcare providers and research organizations to provide large-scale genetic sequencing to support medical research efforts,”

There are three main reasons why many people in the biotech community and government have expressed concerns about China’s access to American DNA data.

In the “60 Minutes” interview, Evanina discussed the very likely scenario in which Chinese companies would be able to micro-target American individuals and offer customized preventative solutions based on their DNA.

Evanina asked: “Do we want to have another nation systematically eliminate our healthcare services? Are we okay with that as a nation?”

The second concern is that China may use DNA to track and attack American individuals. As the USCC report states: “China could target vulnerabilities in specific individuals brought to light by genomic data or health records. Individuals targeted in such attacks would likely be strategically identified persons, such as diplomats, politicians, high-ranking federal officials or military leadership.”

The third concern is that China may devise bioweapons to target non-Asians. Steven Mosher, president of the Population Research Institute, discussed it in his article “What Will China Do With Your DNA?” published by The Epoch Times in March 2019.

He wrote: “We know that the Asian genome is genetically distinct from the Caucasian and African in many ways. … Would it be possible to bioengineer a very virulent version of, say, smallpox, that was easily transmitted, fatal to other races, but to which the Chinese enjoyed a natural immunity? … Given our present ability to manipulate genomes, if such a bio-weapon can be imagined, it can probably – given enough time and resources – be realized.”

An article from Technocracy said: “China’s aggressive collection of American DNA should be doubly alarming because it can only spell one ultimate outcome: biowarfare. That is, genetically engineering viruses or other diseases that will be selectively harmful to U.S. populations.”

Continue Reading

Chat

Trending